Next Article in Journal
Chemical Composition of Laurencia obtusa Extract and Isolation of a New C15-Acetogenin
Next Article in Special Issue
Investigation of Absorption Routes of Meloxicam and Its Salt Form from Intranasal Delivery Systems
Previous Article in Journal
Sulfated Alginates as Heparin Analogues: A Review of Chemical and Functional Properties
Previous Article in Special Issue
Amorphous-Amorphous Phase Separation in API/Polymer Formulations
Article Menu
Issue 5 (May) cover image

Export Article

Open AccessArticle

Application of Soluplus to Improve the Flowability and Dissolution of Baicalein Phospholipid Complex

School of Pharmacy, Nanjing Medical University, Nanjing 211166, China
Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese, Nanjing 210028, China
Jiangsu Province Academy of Traditional Chinese Medicine, Nanjing 210028, China
State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 211198, China
Authors to whom correspondence should be addressed.
Academic Editors: Guy Van den Mooter, Holger Grohganz and Korbinian Löbmann
Molecules 2017, 22(5), 776;
Received: 29 March 2017 / Revised: 3 May 2017 / Accepted: 8 May 2017 / Published: 11 May 2017
(This article belongs to the Collection Poorly Soluble Drugs)
PDF [3023 KB, uploaded 11 May 2017]


In this study, a novel ternary complex system (TCS) composed of baicalein, phospholipids, and Soluplus was prepared to improve the flowability and dissolution for baicalein phospholipid complex (BPC). TCS was characterized using differential scanning calorimetry (DSC), infrared spectroscopy (IR), powder X-ray diffraction (PXRD), and scanning electron microscopy (SEM). The flowability, solubility, oil–water partition coefficient, in vitro dissolution, and in vivo pharmacokinetics of the system were also evaluated. DSC, IR, PXRD, and SEM data confirmed that the crystal form of baicalein disappeared in BPC and TCS. Furthermore, the angle of repose of TCS of 35° indicated an improvement in flowability, and solubility increased by approximately eight-fold in distilled water when TCS was compared with BPC (41.00 ± 4.89 μg/mL vs. 5.00 ± 0.16 μg/mL). Approximately 91.24% of TCS was released at the end of 60 min in 0.5% SDS (pH = 6.8), which suggested that TCS could improve the dissolution velocity and extent. Moreover, TCS exhibited a considerable enhancement in bioavailability with higher peak plasma concentration (25.55 μg/mL vs. 6.05 μg/mL) and increased AUC0–∞ (62.47 μg·h/mL vs. 50.48 μg·h/mL) with 123.75% relative bioavailability compared with BPC. Thus, Soluplus achieved the purpose of improving the flowability and solubility of baicalein phospholipid complexes. The application of Soluplus to phospholipid complexes has great potential. View Full-Text
Keywords: baicalein; phospholipid complex; soluplus baicalein; phospholipid complex; soluplus

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

Fan, J.; Dai, Y.; Shen, H.; Ju, J.; Zhao, Z. Application of Soluplus to Improve the Flowability and Dissolution of Baicalein Phospholipid Complex. Molecules 2017, 22, 776.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Molecules EISSN 1420-3049 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top